Wednesday, July 15, 2020
wellness India Expo
Home Tags DCGI

Tag: DCGI

Bharat Biotech’s COVID-19 vaccine ‘COVAXIN’ gets DCGI nod, human trials to...

Human trials of India’s first indigenous experimental vaccine against COVID-19, COVAXIN, developed by Bharat Biotech is set to begin across India in July........................

CSIR-CDRI’s COVID-19 drug candidate Umifenovir secures DCGI approval for phase III...

This drug has a good safety profile and acts by preventing the entry of virus into human cells and also by priming the immune system......................

Sun Pharma initiates Phase II clinical trial of first phytopharma drug...

Clinical trial of the drug that has shown anti-SARS-CoV-2 effects in in-vitro studies conducted in collaboration with ICGEB will be conducted across 12 centers in India in 210 patients; results expected by October 2020.............................

DCGI approves Nintedanib for the treatment of systemic sclerosis-associated interstitial lung...

Being the first and only approved treatment option available for people living with SSc-ILD, the approval constitutes a breakthrough in an area of high unmet need. Following the FDA’s approval in September 2019, Nintedanib in SSc-ILD has so far been approved in 15 countries including the European Union, Canada, Japan and Brazil.................

CDSCO issues alert on Medtronic’s pacemakers, company says no product recall

The CDSCO has advised patients with specific pacemakers from Medtronic to seek immediate medical assistance if they feel dizzy, light-headed, severe short breath or loss of consciousness. Meanwhile, the company has said it is in talks with the regulator............

Govt notifies new rules for clinical trials, ISCR hails the move

Aimed at reducing the market entry of drugs in India, the ones approved for use in European countries and the United States will be allowed in the country if the Indian patients are included in the earlier trials held abroad...................

In a first, DCGI approves clinical trials for plastic surgery and...

The government for the first time has given approval to a chain of dermatology and plastic surgery centres for conducting clinical trials and drug development for skin, hair and other plastic surgery medications, cosmetology and cosmetic surgery devices in India...…………...

DCGI approves Brintellix in India for major depressive disorder

Lundbeck India has announced the launch of Brintellix (Vortioxetine), a novel multimodal antidepressant, which has been specifically designed to inhibit serotonin reuptake and modulate serotonergic receptor activity of the neurons in the brain of affected patients...…………...

MTaI’s seminar educates MedTech professionals on new European medical device rules

While speakers from DuPont educated audience on new rules in Europe, the regulatory experts present at the seminar agreed that the medical device regulations are changing steadfastly around the world and many of these new guidelines will impact packaging...……..

DCGI to discuss drug tracking mechanism with pharma firms on 25th...

The Drug Controller General of India will be discussing the introduction of trace and track mechanism for top 300 drug brands that are sold in India with representatives of 66 pharmaceutical companies..............